Optimizing initial vancomycin dosing in burn patientsELLIGSEN, Marion; WALKER, Sandra A. N; WALKER, Scott E et al.Burns. 2011, Vol 37, Num 3, pp 406-414, issn 0305-4179, 9 p.Article

Analysis of Vancomycin Therapeutic Drug Monitoring Trends at Pediatric HospitalsMOFFETT, Brady S; EDWARDS, Morven S.The Pediatric infectious disease journal. 2013, Vol 32, Num 1, pp 32-35, issn 0891-3668, 4 p.Article

The structural basis for induction of VanB resistanceDONG, Steven D; OBERTHUR, Markus; LOSEY, Heather C et al.Journal of the American Chemical Society. 2002, Vol 124, Num 31, pp 9064-9065, issn 0002-7863Article

Linear immunoglobulin A disease and vancomycin: letter in replyINGEN-HOUSZ-ORO, S; VALEYRIE-ALLANORE, L; CHANAL, J et al.British journal of dermatology (1951). 2014, Vol 171, Num 6, pp 1602-1604, issn 0007-0963, 3 p.Article

Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patientsBARRIGA, F. J; VARAS, M; POTIN, M et al.Medical and pediatric oncology. 1997, Vol 28, Num 3, pp 196-200, issn 0098-1532Conference Paper

Synthesis and antibacterial activity of N-acyl vancomycinsNAGARAJAN, R; SCHABEL, A. A; OCCOLOWITZ, J. L et al.Journal of antibiotics (Tokyo. 1968). 1988, Vol 41, Num 10, pp 1430-1438, issn 0021-8820Article

Focal injection of vancomycin combined with surgical debridement-dermatoplasty in the treatment of pseudo-epitheliomatous granulomaJIANG, Du-Yin; FU, Xiao-Bing; ZONG, Xian-Lei et al.Burns. 2010, Vol 36, Num 4, pp 552-557, issn 0305-4179, 6 p.Article

Streptogramin resistance patterns and virulence determinants in vancomycin-susceptible enterococci isolated from multi-component deli saladsCHRISTENSEN, E. A; JOHO, K; MATTHEWS, K. R et al.Journal of applied microbiology (Print). 2008, Vol 104, Num 5, pp 1260-1265, issn 1364-5072, 6 p.Article

Vancomycin nephrotoxicity: myths and factsGUPTA, A; BIYANI, M; KHAIRA, A et al.Netherlands journal of medicine. 2011, Vol 69, Num 9, pp 379-383, issn 0300-2977, 5 p.Article

Evaluation of chromogenic media for the isolation of vancomycin-resistant enterococci from stool samplesASIR, K; WILKINSON, K; PERRY, J. D et al.Letters in applied microbiology. 2009, Vol 48, Num 2, pp 230-233, issn 0266-8254, 4 p.Article

Stridor accompanying red man's syndrome following perioperative administration of vancomycinAPUYA, Jesus; KLEIN, E. F.Journal of clinical anesthesia. 2009, Vol 21, Num 8, pp 606-608, issn 0952-8180, 3 p.Article

An antibiotic order form intervention does not improve or reduce vancomycin useBOLON, Maureen K; ARNOLD, Alana D; FELDMAN, Henry A et al.The Pediatric infectious disease journal. 2005, Vol 24, Num 12, pp 1053-1058, issn 0891-3668, 6 p.Article

Vancomycin-resistant Enterococcus raffinosus : Molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance programWILKE, W. W; MARSHALL, S. A; COFFMAN, S. L et al.Diagnostic microbiology and infectious disease. 1997, Vol 29, Num 1, pp 43-49, issn 0732-8893Article

Treatment of pediatric febrile neutropenia in the era of vancomycin-resistant microbes. CommentaryKLINE, Ronald M; BAORTO, Elizabeth P; GAMIS, Alan S et al.Pediatric blood & cancer. 2005, Vol 44, Num 3, pp 207-214, issn 1545-5009, 8 p.Article

Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococciSAKKA, V; TSIODRAS, S; GALANI, L et al.Clinical microbiology and infection. 2008, Vol 14, Num 1, pp 14-21, issn 1198-743X, 8 p.Article

Rapid detection and differentiation method of VanA, VanB and VanC phenotypes in vancomycin-resistant enterococciHANAKI, Hideaki; YAMAGUCHI, Yoshio; NOMURA, Syuichi et al.International journal of antimicrobial agents. 2004, Vol 23, Num 5, pp 502-505, issn 0924-8579, 4 p.Article

Use of Vancomycin in PediatricsDEHORITY, Walter.The Pediatric infectious disease journal. 2010, Vol 29, Num 5, pp 462-464, issn 0891-3668, 3 p.Article

Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant Enterococcus colonizationKACHROO, Sumesh; DAO, Thanh; ZABANEH, Firas et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 3, pp 381-385, issn 1060-0280, 5 p.Article

Consequences of vancomycin-resistant Enterococcus in liver transplant recipients : a matched control studyGEARHART, Michelle; MARTIN, Jill; BASS, Maryetta et al.Clinical transplantation. 2005, Vol 19, Num 6, pp 711-716, issn 0902-0063, 6 p.Article

Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemiaPEEL, T; CHENG, A. C; SPELMAN, T et al.Clinical microbiology and infection. 2012, Vol 18, Num 4, pp 388-394, issn 1198-743X, 7 p.Article

The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MICHONGBIN CHEN; YUDONG LIU; WENJIA SUN et al.Diagnostic microbiology and infectious disease. 2011, Vol 71, Num 3, pp 301-303, issn 0732-8893, 3 p.Article

Rapid detection of Staphylococcus aureus strains having reduced susceptibility to vancomycin using a chemiluminescence-based drug-susceptibility testTAJIMA, Yutaka; KOMATSU, Mitsutaka; ITO, Teruyo et al.Journal of microbiological methods. 2007, Vol 70, Num 3, pp 434-441, issn 0167-7012, 8 p.Article

Sensorineural hearing loss associated with intrathecal vancomycinKLIBANOV, Olga M; FILICKO, Joanne E; DESIMONE, Joseph A et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 1, pp 61-65, issn 1060-0280, 5 p.Article

The role of vancomycin in the treatment paradigmSTEVENS, Dennis L.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, S51-S57, SUP1Article

Antibiotic optimization via in vitro glycorandomizationXUN FU; ALBERMANN, Christoph; JIQING JIANG et al.Nature biotechnology. 2003, Vol 21, Num 12, pp 1467-1469, issn 1087-0156, 3 p.Article